The 2-Minute Rule for Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advancements study located that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which